This page has been archived on the Web
Information identified as archived is provided for reference, research or recordkeeping purposes. It is not subject to the Government of Canada Web Standards and has not been altered or updated since it was archived. Please contact us to request a format other than those available.
Procter & Gamble Recalls Mouthwash
- Starting date:
- July 13, 2011
- Posting date:
- July 13, 2011
- Type of communication:
- Information Update
- Subcategory:
- Drugs, Natural health products
- Source of recall:
- Health Canada
- Issue:
- Product Safety, Microbial Hazard, Contamination
- Audience:
- General Public
- Identification number:
- RA-110005217
Health Canada is advising Canadians that Procter & Gamble is conducting a voluntary recall of Oral B Anti-Cavity Dental Rinse – Alcohol Free (NPN 02129930) and Oral-B Anti-Bacterial with Fluoride – Alcohol Free Daily Use Mouthrinse (DIN 02130823).
The products are being recalled due to possible microbial contamination. Procter & Gamble is requesting that retailers immediately stop sale of these products and is also advising consumers to discard the affected product and contact them for a refund by calling 1-800-566-7252, Monday to Friday between 9:00 a.m. to 5:00 p.m.
According to Procter & Gamble, if present, the microbial level poses virtually no risk to healthy people. However, people with severely weakened immune systems, such as those with cystic fibrosis may be more susceptible to adverse health effects. As such, Health Canada reminds Canadians who have concerns about these products to consult with their health care practitioner.
Health Canada is monitoring the recall by Procter & Gamble. Should new additional safety information be identified, Health Canada will provide an update to Canadians.
To report a suspected adverse reaction to these or other health products, please contact the Canada Vigilance Program of Health Canada toll-free at 1-866-234-2345, or complete a Canada Vigilance Reporting Form and send it to us using one of these methods:
- Fax: 1-866-678-6789
- E-mail: CanadaVigilance@hc-sc.gc.ca
- Internet: MedEffect Canada
-
Mail: Canada Vigilance Program
Marketed Health Products Directorate
Ottawa, ON, Address Locator 0701C
K1A 0K9
Media enquiries
Health Canada
613-957-2983
Public enquiries
613-957-2991
1-866-225-0709